R&D Views & Analysis | pharmaphorum

Views & Analysis

R&D

Challenges and opportunities in synthetic clinical trials

Of the many changes coming to clinical trials, one of the biggest potential paradigm shifts on the horizon is the elimination of placebo groups in some trials in favour of synthetic control

R&D

Group of people in lab where Quillaja saponaria trees grow

Plants and vaccine adjuvants: BSI’s sustainable trees in a l...

This time last year, Croda Pharma and Botanical Solution Inc (BSI) announced that they’d entered into a strategic collaboration agreement to support the sustainable sourcing of pharmaceutic

R&D

A greener catalysis: Talking sustainable, scalable chemistry...

As King’s College London (KCL) scientists are once more in the headlines – this time with new ‘plug and play’ drug delivery technology that could offer a

R&D

Overcoming challenges with maternal vaccine trials

Childhood vaccines have proven to be one of the most effective public health interventions to reduce infant and child mortality.

R&D

FT US Pharma and Biotech Summit: Live coverage

This week, pharmaphorum heads to the Big Apple for the FT US Pharma and Biotech Summit, a one-day event where executives from some of the world’s top pharma companies will come together to

R&D